National Pharmacy Association (NPA) - News updates

Certain pages on this news feed are only available to NPA members and hence requires members to log-in accordingly

End of month submissions and claiming payments (England)

COVID-19: MHRA takes action to halt sales of finger-prick coronavirus antibody testing kits

A further advance payment of £50m for community pharmacy will be paid on June 1 2020

Heatwave Plan for England now includes new COVID-19-specific resources

COVID-19: NHS Test and Trace programme launched (England)

Professional organisations collaborate to give independent community pharmacists easier access to essential medicines information

Government loading more debt onto pharmacies makes action on C-19 costs urgent, says National Pharmacy Association

  Ministers have agreed to inject a further £50m of advance funding into community pharmacies at the end of May, according to an announcement by the Pharmaceutical Services Negotiating Committee (PSNC) today. The NPA said its members will benefit in the short term, but warned that this cash injection loads new debt onto pharmacies, many of which have little prospect of being able to pay it back. NPA chief executive, Mark Lyonette, said: “It is now more urgent than ever that the government fulfils commitments to repay all the extra costs incurred by pharmacies during the COVID-19 pandemic. “Today’s announcement make talks on cost recovery even more urgent. We need assurances on the medium term position, because this new advance effectively increases the level of pharmacies’ debt to government.  Many independent pharmacies will struggle to pay it back and should never be asked to do so. “This advance will make it easier for our members to pay their bills, for now, and to keep vital services going. But it isn’t new money and doesn’t get to the root of the funding problems. “Pharmacists are bearing a heavy financial burden in order to keep people safe and well.  As caring health care professionals, pharmacists have kept their doors open, often at considerable personal cost.…

Government launches NHS Test and Trace service

NPA response to DoH Consultation on the Pharmaceutical Services Regulations (Northern Ireland) 1997

Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19